Capitalize on the final quarter of 2025 to grow revenue, receive Section 179 tax benefits, and build a more profitable,
resilient practice in 2026. The fourth quarter is often the busiest and most overlooked time for physicians to make
strategic business decisions. In today’s climate of declining insurance reimbursements and rising costs, Q4 presents
a unique opportunity to strengthen your practice for lasting financial success.
The Neurogenx® Treatment is an effective, FDA-cleared solution for chronic nerve conditions and
neuropathy that improves patient outcomes while serving as a turnkey business-building opportunity—this
treatment has been a highly successful cash-based model for many providers, driving practice growth and
boosting revenue.
Complimentary Marketing Business Solutions Program Receive expert marketing tools, strategies, and support to launch or grow your Neuropathy program—at no extra cost.
Our flexible payment plans help you invest in your practice growth without disrupting cash flow.
to secure your exclusive savings and receive a complimentary marketing kick-start package when you purchase the Neurogenx NervePro 2.0 by December 31, 2025.
Neurogenx’s FDA-cleared device relieves nerve pain, numbness, and tingling in 87% of patients. Independent lab studies confirm its effectiveness in reducing neuropathic symptoms and promoting nerve healing, making it a trusted, non-invasive solution for chronic nerve conditions.
Neurogenx treatment builds a lucrative neuropathy business, boosting revenue, attracting patients and referrals, and fostering loyalty. Neurogenx Providers lead in innovative neuropathic care, driving their competitive edge and sustainable growth.
The Neurogenx device promotes nerve repair by improving blood flow, reducing inflammation, facilitating cellular regeneration, and triggering the release of natural pain-relieving chemicals—all while avoiding narcotics and invasive interventions.
Neurogenx® offers ongoing clinical training, advocacy resources, educational tools, and patient marketing material—helping providers and staff engage their
communities and drive innovation in chronic nerve
conditions..
Preferred Neurogenx Provider
An innovative, FDA-cleared device designed for advanced neuropathy management in clinical settings. Delivering biosimilar electronic signals at industry-leading frequencies up to 60,000 Hz, it reaches deep tissue to target nerve pain, tingling, burning, numbness, and other hallmark neuropathic symptoms— regardless of their origin.
This cutting-edge technology not only provides effective, non-narcotic relief but also promotes nerve fiber regeneration and enhances sensation. Independent lab studies reveal nerve density increases averaging 165.4%, with some peak improvements up to 395% after treatment.
Clinics using the Neurogenx 4000Pro with NervePRO 2.0 report rapid symptom relief, lasting outcomes, and superior results—even for patients with the most resistant chronic nerve conditions.

"Relief from their neuropathy symptoms"
The Neurogenx therapy is giving many of our patients a great amount of relief from their neuropathy symptoms, including numbness and pain."
- Dr. Darren Silvester

"CET with Neurogenx is very effective…"
"a critical cornerstone in treatment; it also helps patients after entrapment surgery because it dials into the peripheral nerve and combined with the peripheral nerve block, it works well."
- Dr. Stephen Barrett




Now is the time to embrace our innovative neuropathy treatment that elevates patient care and strengthens your business foundation. With an opportunity for a cash-based neuropathy business model, you can simplify operations while maximizing revenue potential.
Take the next step—partner with Neurogenx and transform your practice into a leader in chronic nerve condition management.
Contact us today to learn more and secure your savings opportunity for the coming year.
